Ethyl 2,4,6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in HepG2 cells

Minh Hien Hoang, Yaoyao Jia, Hee Jin Jun, Ji Hae Lee, Dongho Lee, Bang Yeon Hwang, Woo Jin Kim, Hak Ju Lee, Sung-Joon Lee

Research output: Contribution to journalArticle

14 Citations (Scopus)


The present study reports a novel liver X receptor (LXR) activator, ethyl 2,4,6-trihydroxybenzoate (ETB), isolated from Celtis biondii. Using a reporter gene assay, time-resolved fluorescence resonance energy transfer (TR-FRET), and surface plasmon resonance (SPR) analysis, we showed that ETB directly bound to and stimulated the transcriptional activity of LXR-α and LXR-β. In macrophages, hepatocytes, and intestinal cells, ETB suppressed cellular cholesterol accumulation in a dose-dependent manner and induced the transcriptional activation of LXR-α/-β-responsive genes. Notably, ETB did not induce lipogenic gene expression or cellular triglyceride accumulation in hepatocytes. These results suggest that ETB is a dual-LXR modulator that regulates the expression of key genes in cholesterol homeostasis in multiple cells without inducing lipid accumulation in HepG2 cells.

Original languageEnglish
Pages (from-to)4094-4099
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Issue number12
Publication statusPublished - 2012 Jun 15



  • Celtis biondii
  • Cholesterol
  • Ethyl 2,4,6-trihydroxybenzoate
  • Liver X receptor

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this